NeoImmuneTech gets IND clearance for NT-I7 trial in locally recurrent SCCHN

This article was originally published here

The investigator-initiated trial is being conducted by Hyunseok Kang, M.D., Associate Professor of Clinical Medicine at the University of California, San Francisco. Over half a million people worldwide

The post NeoImmuneTech gets IND clearance for NT-I7 trial in locally recurrent SCCHN appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply